IRS2 and Alzheimer disease: However, it has been reported that miR-7 is overexpressed in the cerebellum and frontal cortex of AD patients, reducing the expression of IRS-2, impairing the insulin signaling pathway [140], and possibly modulating Aβ metabolism during disease progression.